在囊性纤维化中婴儿肺功能:现实世界的研究
Michele Arigliani1,2, Sidrah Chaudhry1, Rossa Brugha1,2
1Paediatric Respiratory Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Pediatric pulmonology
|May 6, 2025
概括
婴儿肺功能异常在囊性纤维化中很常见,但临床治疗主要依赖于症状,而不是肺功能测试. 现实世界的数据显示,即使肺功能异常,管理变化也很少发生.
科学领域:
- 儿科肺病学 儿科肺病学
- 囊性纤维化研究 囊性纤维化研究
- 婴儿肺功能评估 婴儿肺功能评估
背景情况:
- 肺功能异常经常在患有囊性纤维化 (IwCF) 的婴儿中观察到.
- 有限的现实世界的数据存在于IwCF.这些异常的临床意义.
- 了解早期肺功能变化对于IwCF的及时干预至关重要.
研究的目的:
- 调查患有囊性纤维化症的婴儿肺功能异常的患病率.
- 评估IwCF中肺功能测试结果与临床管理决策之间的相关性.
- 分析微生物学和临床发现对IwCF治疗调整的影响.
主要方法:
- 从IwCF (2012-2018) 获得的婴儿肺功能数据的回顾性分析,在一个中心.
- 肺功能测试 (SF6肺清除指数[LCI],FRC,FEV0.5) 在3个月,1年和2年进行.
- 对微生物学,抗生素处方和临床管理变化的分析围绕肺功能评估.
主要成果:
- 肺功能异常 (zLCI升高) 存在于31%的3个月大,28%的1岁大,和19%的2岁大.
- 在微生物学结果呈阳性或胸部异常的病例中,100%的肺功能异常患者和86%的肺功能正常患者接受了抗生素处方或治疗方法的改变.
- 只有12%的肺功能异常但临床发现正常的病例发生了管理变化.
结论:
- 患有囊性纤维化婴儿的临床治疗主要取决于临床发现,而不仅仅取决于肺功能测试结果.
- 异常的肺功能 (升高的FRC或LCI) 在这个现实世界队列中对临床管理决策产生了边际影响.
- 需要进行进一步的研究,以优化将肺功能数据集成到IwCF的临床决策中.
相关概念视频
Lung Capacity
47.9K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
47.9K
Cystic Fibrosis: Management
97
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
97
Cystic Fibrosis: Pathogenesis
136
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
136
Pulmonary Function Tests
255
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
255
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K


